Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Removes waste products (e.g., urea, creatinine) and excess fluid from the blood through peritoneal dialysis by diffusion and osmosis across the peritoneal membrane.
Dianeal PD-1 with Dextrose 1.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create a concentration gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the peritoneal cavity via diffusion and ultrafiltration.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges daily; dwell time 4-6 hours; concentration selected based on ultrafiltration needs.
2 L intraperitoneally via continuous ambulatory peritoneal dialysis (CAPD) four times daily, with dwell times of 4-6 hours each. For automated peritoneal dialysis (APD), 2 L per cycle with 4-5 cycles overnight.
None Documented
None Documented
The terminal half-life of icodextrin (as total icodextrin-derived oligosaccharides) is approximately 5-8 hours after a single dwell, reflecting clearance from the plasma compartment. Clinically, sustained levels can occur with repeated exchanges.
Dextrose half-life is approximately 1-2 hours in normal individuals; with peritoneal dialysis, elimination is governed by dialysate dwell time and peritoneal transport characteristics, typically 4-6 hours for complete absorption.
Delflex-LM with Dextrose 1.5% (icodextrin) is a peritoneal dialysis solution. Icodextrin is metabolized to oligosaccharides and primarily eliminated via the peritoneal cavity during dialysis. Renal excretion is minimal (<1%). The majority of icodextrin and its metabolites are removed with the dialysate effluent.
Renal: dialysis (peritoneal) accounts for >95% of dextrose elimination; minimal renal excretion (<5% unchanged dextrose). Biliary/fecal: negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution